The present invention relates to the new crystalline form of pitavastatin half calcium salt, this new crystalline form is hereinafter referred to as polymorphic form form A, B, C, D, E and F, and non-crystalline state form.In addition, the present invention relates to the preparation method of these crystalline forms and non-crystalline state form and comprise these crystalline forms or the pharmaceutical composition of non-crystalline state form.
